Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The current status of chemodectomas.

J F Marquez, E C James, R J Gardner

    The American Surgeon
    |March 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    This study analyzes chemodectomas, presenting two cases: a rare malignant intrathoracic tumor and a common carotid body tumor. It discusses clinical recognition and treatment for these neuroendocrine tumors.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Shape discrimination by total curvature, with a view to cancer diagnostics.

    Journal of microscopy·2005
    Same author

    Clinical features of a large Australian pedigree with episodic ataxia type 1.

    Movement disorders : official journal of the Movement Disorder Society·2001
    Same author

    A new autosomal dominant pure cerebellar ataxia.

    Neurology·2001
    Same author

    Prevalence and nature of connexin 26 mutations in children with non-syndromic deafness.

    The Medical journal of Australia·2001
    Same author

    Dominant intermediate Charcot-Marie-Tooth neuropathy maps to chromosome 19p12-p13.2.

    American journal of human genetics·2001
    Same author

    Transient neonatal diabetes mellitus in a child with paternal uniparental disomy of chromosome 6.

    Journal of pediatric endocrinology & metabolism : JPEM·2001
    Same journal

    Complete Response of Merkel Cell Carcinoma to Immunotherapy and Single-Fraction Radiotherapy Following Severe COVID-19 Infection: A Case Report and Review of Immune Mechanism.

    The American surgeon·2026
    Same journal

    Perioperative Acute Myocardial Infarction in Non-Cardiac Operations: A National Analysis.

    The American surgeon·2026
    Same journal

    Outcomes of Completion Cholecystectomy: Association With Patient Comorbidity in a National Database.

    The American surgeon·2026
    Same journal

    Building the Conversation: Editorial Stewardship in Contemporary Surgical Publishing.

    The American surgeon·2026
    Same journal

    Musculoskeletal Pain in Surgeons on Operating Days.

    The American surgeon·2026
    Same journal

    Splenectomy During Cytoreductive Surgery: Marker of Surgical Burden or Independent Predictor of Morbidity?

    The American surgeon·2026
    See all related articles

    Area of Science:

    • Oncology
    • Pathology
    • Surgical Oncology

    Background:

    • Chemodectomas are rare neuroendocrine tumors arising from paraganglia.
    • Understanding their diverse clinical presentations and treatment is crucial.

    Observation:

    • Presents two cases of chemodectomas: a malignant intrathoracic tumor and a carotid body tumor.
    • The intrathoracic tumor case was fatal despite palliative pneumonectomy.
    • The carotid body tumor was successfully treated with subadventitial carotid excision.

    Findings:

    • Highlights the rarity and poor prognosis of malignant intrathoracic chemodectomas.
    • Demonstrates the efficacy of surgical management for common carotid body tumors.
    • Emphasizes the importance of comprehensive analysis including historical, anatomic, and pathologic features.

    Related Experiment Videos

    Implications:

    • Informs clinical recognition and treatment strategies for various chemodectoma types.
    • Underscores the need for early diagnosis and tailored therapeutic approaches.
    • Contributes to the understanding of chemodectoma behavior and patient outcomes.